immunity

There are three reasons behind Israel still not returning to normal life.

Maj.-Gen. Itzik Turgeman, head of the IDF Technological and Logistics Directorate, said that 81% of army personnel have either been vaccinated or recovered from the virus.

"Removing the restrictions on social distancing and applying the green passport on the eighth day after receiving the second vaccine is too early."

Immunai is on a mission to reprogram the immune system to advance personalized medicine to better detect, diagnose and treat diseases, company co-founder Noam Solomon told The Jerusalem Post.

"We won't get back to normal quickly," Dale Fisher, chairman of WHO's Outbreak Alert and Response Network.

More than 1 million Americans have received a first dose of a vaccine since Dec. 14, according to the U.S. Centers for Disease Control, or only about 0.3% of the population.

Some 23% of Israeli's don't know if the vaccine is safe, 17% think it is not safe, and 6% are sure it is not safe.

Researchers called for a larger study of humoral immunity, saying that their small study emphasizes the need for further research.

The study, carried out in a joint effort by British and Guinean scientists, is the world's largest and most comprehensive one to date to examine survivors of the Ebola virus.

The patient tested positive for coronavirus a second time, and antibody tests showed that she had no antibodies against the virus. Researchers said they were two different strains of the virus.